Warfarin associated with higher risk of osteoporotic fracture than dabigatranObservational study involved Asian patients with non-valvular atrial fibrillation Marathons may interfere with emergency careResearchers find increased MI and cardiac arrest mortality in non-participants Patients’ failure to complete cardiac rehab costs health system millions New Canadian guidelines for prevention and treatment of hypertension in children Address health behaviour management, when to start drug therapy, choice of therapy, and therapy goals. Relax, the new oral anticoagulants don't need monitoring, Canadian experts say No evidence of benefit for such a practice in atrial fibrillation patients, review concludes Long-term, full-scope pharmacist care in hypertension would provide cost savings and health benefits Projected cost savings in Canada over 30 years estimated to be more than $15.7 billion. What’s new in the 2017 Canadian hypertension guidelines? Annual update reviews the diagnosis, risk assessment, prevention and treatment of hypertension in Canadian adults Moderate drinking linked to lower risk of some—but not all—heart conditions A more nuanced approach to role of alcohol in heart health is needed, researchers PCSK9 inhibitor cuts cardiovascular event rate in major trial But injectable cholesterol-lowering biologic shows no mortality benefit over two years Compliance poor with new oral anticoagulants One in three seniors not taking the drugs as directed, Ontario study shows First Previous 35 36 37 38 39 Next Last
